A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)

[1]  L. Solomon.  Functional vitamin B12 deficiency in advanced malignancy: implications for the management of neuropathy and neuropathic pain , 2016, Supportive Care in Cancer.

[2]  G. Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity. , 2015, Current opinion in neurology.

[3]  L. Vitetta,et al.  Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency , 2015, Supportive Care in Cancer.

[4]  K. Kimpinski,et al.  Revisiting the Evidence for Neuropathy Caused by Pyridoxine Deficiency and Excess , 2014, Journal of clinical neuromuscular disease.

[5]  L. Vitetta,et al.  Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. , 2013, Clinical nutrition.

[6]  M. Koltzenburg,et al.  Chemotherapy‐induced peripheral neurotoxicity: A critical analysis , 2013, CA: a cancer journal for clinicians.

[7]  S. Choi,et al.  Oral Vitamin B12 Replacement: An Effective Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients , 2011, Annals of Surgical Oncology.

[8]  Bruno D. Zumbo,et al.  The operating characteristics of the nonparametric Levene test for equal variances with assessment and evaluation data , 2011 .

[9]  Bruno D. Zumbo,et al.  A New Nonparametric Levene Test for Equal Variances , 2010 .

[10]  A. Silvani,et al.  Vitamin E neuroprotection for cisplatin neuropathy , 2010, Neurology.

[11]  U. Jaehde,et al.  Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity , 2009, Anti-cancer drugs.

[12]  Y. Sunada,et al.  Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 , 2009, Supportive Care in Cancer.

[13]  A. Dans,et al.  Vitamin B for treating peripheral neuropathy. , 2008, The Cochrane database of systematic reviews.

[14]  G. Nicolini,et al.  Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. , 2008, Frontiers in bioscience : a journal and virtual library.

[15]  Wolfgang Grisold,et al.  Chemotherapy‐induced neuropathy , 2008, Journal of the peripheral nervous system : JPNS.

[16]  Jeffrey A. Cohen,et al.  The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy. , 2008, Oncology nursing forum.

[17]  R. Rao,et al.  Chemotherapy-induced neuropathy , 2007, Current oncology reports.

[18]  Jin-Hwang Liu,et al.  Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. , 2007, The oncologist.

[19]  A. Argyriou,et al.  A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results , 2006, Supportive Care in Cancer.

[20]  C. Meyers,et al.  Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients , 2006, Current opinion in obstetrics & gynecology.

[21]  A. Pace,et al.  Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial , 2005, Neurology.

[22]  M. Gilbert,et al.  Chemotherapy-induced peripheral neuropathy. , 2005, Oncology nursing forum.

[23]  N. Ifrah,et al.  Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions , 2004, Clinical Cancer Research.

[24]  W. Scheithauer,et al.  Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  N. Aaronson,et al.  Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. , 1997, Journal of clinical epidemiology.

[26]  G. Tisman,et al.  New assay for the rapid determination of plasma holotranscobalamin II levels: Preliminary evaluation in cancer patients , 1993, American journal of hematology.

[27]  Cheryl L. Rock,et al.  Present Knowledge in Nutrition, 6th ed , 1992 .

[28]  J. Rogin,et al.  Peripheral sensory neuropathy and cisplatin chemotherapy , 1984, Neurology.

[29]  D. Weir,et al.  Folate/vitamin B12 inter-relationships. , 1994, Essays in biochemistry.

[30]  R. J. Cersosimo,et al.  Cisplatin neurotoxicity. , 1989, Cancer treatment reviews.